Related Experiment Video
Updated: Jun 18, 2026
09:37
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
mTOR signaling: PLD takes center stage
1Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
Cell Cycle (Georgetown, Tex.)
|October 18, 2008
Summary
Phospholipase D (PLD) directly connects to the TSC-Rheb pathway, revealing PLD1 as a key activator of mTORC1 signaling. This study also suggests a novel role for PLD in sensing nutrients.
Area of Science:
- Cellular Biology
- Molecular Signaling
- Biochemistry
Background:
- The mammalian target of rapamycin (mTOR) pathway regulates cellular functions in response to nutrients and stimuli.
- mTOR complex 1 (mTORC1) integrates signals via the TSC-Rheb pathway.
- Lipid signaling involving phospholipase D (PLD) and phosphatidic acid (PA) is known to influence mTORC1.
Purpose of the Study:
- To investigate the direct connection between the TSC-Rheb pathway and PLD-mediated signaling.
- To elucidate the role of PLD1 in the activation of mTORC1.
- To explore the potential of PLD as a nutrient sensor in cellular signaling.
Main Methods:
- Investigated the interaction between Rheb and PLD1.
- Analyzed the impact of PLD1 on mTORC1 activation.
- Proposed mechanistic models for PLD-mTOR signaling based on recent findings.
Main Results:
- Demonstrated that PLD1 acts as a direct effector of Rheb in activating mTORC1.
- Established a direct link between the TSC-Rheb pathway and the PLD-PA signaling cascade.
- Suggested a novel function for PLD in sensing nutrient availability.
Conclusions:
- PLD1 is a crucial component linking Rheb signaling to mTORC1 activation.
- Phosphatidic acid and PLD play significant roles in the mTORC1 signaling network.
- Further research is needed to validate proposed mechanistic models of PLD-mTOR signaling.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...